Picture EBD Group BIO-Europe 2026 Köln Cologne to 31 Jul 650x100px

Life-Sciences-Europe.com
The European Life Sciences Web Portal

This is a free web portal for the life sciences in Europe and Israel... » read more

Ottobock Acquires Fesia Technology, S.L., Spain (2026-07-07)
> Strategic expansion of the product portfolio in Functional Electrical Stimulation (FES) for neuro-orthotics > Functional Electrical Stimulation supports the restoration of functional movement in a wide range of neurological conditions Ottobock SE & Co. KG...
Astex & Genentech: Collaboration & License Agreement (2026-07-06)
> Collaboration leverages Astex’s industry-leading, fragment-based drug discovery capability to target a key cell-cycle-dependent regulator in breast cancer > Astex to receive an upfront and potential milestone payments, totalling more than $490 million as wel...
Novartis Acquires Myricx Bio for up to $1.5b; $1.1b Upfront (2026-07-06)
> Adds potential first-in-class, N-myristoyltransferase inhibitor (NMTi) antibody-drug conjugate (ADC) payload platform, designed to address resistance to current payloads > Strengthens the Novartis oncology pipeline with two lead ADC assets and a broader payloa...
AlzeCure: Out-licenses Alzheimer Project to QuantumCell ApS (2026-07-01)
AlzeCure Pharma AB (publ) (“AlzeCure”) (FN STO: ALZCUR), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer’s disease and pain, announced today that the company has entered into an out-licensing and collaboration agreemen...
Ipsen Acquires Memo Tx for up to >€700m with €200m Upfront (2026-07-01)
> Acquisition focused on clinical-stage program potravitug, a first-in-class BK polyomavirus monoclonal antibody > Totality of evidence from the Phase II SAFE KIDNEY II trial supports initiation of pivotal Phase II/III trial later this year > Ipsen expands ra...
Klick Health Acquires Oxford PharmaGenesis (2026-06-30)
Bonded by breakthroughs and a laser focus on their people and clients, leading independent agencies join forces to deliver accelerated commercial success through broadened medical affairs and communications, market access, and RWE/HEOR offerings; the most advanced ...
EMBL Spin-off Epitome Tx Launches with €4m in Total Funding (2026-06-30)
> €4 million in total funding comprising an oversubscribed €2 million pre-seed round co-led by XISTA Science Ventures and Caesar Ventures and €2 million in non-dilutive grant funding > EMBL spin-off developing CADENCE, a next-generation epigenome editing p...
KyooBe’s Pathogen Inactivation Available via Fraunhofer IZI (2026-06-30)
Recent infectious disease events—from hantavirus outbreaks and meningitis cases to recurring disease outbreaks in livestock farming—highlight the need for flexibly scalable vaccine manufacturing processes. To address this challenge, Stuttgart-based technology c...
Merck KGaA to Acquire Bio-Techne for $11.3b (€9.9b) (2026-06-25)
> Purchase price of US$73 per share in cash represents an enterprise value of US$11.3 billion (EUR 9.9 billion) > Proposed acquisition expected to be immediately accretive to sales growth and EBITDA pre margin post-closing, and EPS pre accretive by year 3 after ...
Merck Announces Healthcare Leadership Changes (2026-06-24)
Miguel Fernández Alcalde has been appointed Head of Global Commercial Strategy. Monia Vial is appointed President of EMD Serono Merck, a leading science and technology company which operates its Healthcare business sector as EMD Serono in the U.S. and Canada,...

Life-Sciences-Europe.com is your doorway to the European life sciences!

[LSE] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in Europe and Israel.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSE] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]